Accumulation of tyrosine hydroxylase messenger RNA molecules in the rat mesencephalon by chronic caffeine treatment

Neuroscience Letters

Volumn 220, Issue 2, 1996, Pages 77-80

  Datta, Ujjwal ^a   Noailles, Pierre A H ^a   Rodriguez, Miguel ^a   Kraft, Madelyne ^a   Zhang, Yong ^a   Angulo, Jesus A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Caffeine; MK 801; Substantia nigra compacta; Tyrosine hydroxylase mRNA; Ventral tegmental area

Indexed keywords

ADENOSINE A2 RECEPTOR ANTAGONIST; CAFFEINE; DIZOCILPINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; CAFFEINE; DIZOCILPINE MALEATE; MALE; MESENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 0030582658     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13213-4     Document Type: Article

References (23)

1. [1] Ackerman, J.M. and White, F.J., A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment, Neurosci. Lett., 117 (1990) 181-187.
2. [2] Angulo, J.A., Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain, J. Neurochem., 58 (1992) 1104-1109.
3. [3] Beitner-Johnson, D. and Nestler, E.J., Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions, J. Neurochem., 57 (1991) 344-347.
4. [4] Beavo, J.A., Rogers, N.L., Crofford, O.B., Hardman, J.G., Sutherland, E.W. and Newman, E.V., Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity, Mol. Pharmacol., 6 (1970) 597-603.
5. [5] Fallon, J.H. and Moore, R.Y., Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum, J. Comp. Neurol., 180 (1978) 545-580.
6. [6] Grima, B., Lamoroux, A., Blanot, F., Biguet, N. and Mallet, J., Complete coding sequence of rat tyrosine hydroxylase mRNA, Proc. Natl. Acad. Sci. USA, 82 (1985) 617-621.
7. [7] Kalivas, P.W. and Weber, B., Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine, J. Pharmacol. Exp. Ther., 245 (1988) 1095-1102.
8. [8] Kalivas, P.W. and Stewart, J., Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity, Brain Res. Rev., 16 (1991) 223-244.
9. [9] Kalivas, P.W. and Duffy, P., Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals, J. Neurosci., 13 (1993) 266-275.
10. [10] Kaplan, G.B., Greenblatt, D.J., Leduc, B.W., Thompson, M.L. and Shader, R.I., Relationship to plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity, J. Pharmacol. Exp. Ther., 248 (1989) 1078-1083.
11. [11] Koob, G.F. and Bloom, F.E., Cellular and molecular mechanisms of drug dependence, Science, 242 (1988) 715-723.
12. [12] Loughlin, S.E. and Fallon, J.H., Substantia nigra and ventral tegmental area projections to cortex: topography and collateralization, Neuroscience, 11 (1984) 425-435.
13. [13] Nehlig, A., Daval, J.-L. and Debry, G., Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Rev., 17 (1992) 139-170.
14. [14] Pellegrino, L.J., Pellegrino, A.S. and Cushman, A.J., A Stereotaxic Atlas of the Rat Brain, Plenum Press, New York, 1979.
15. [15] Robinson, T.E. and Becker, J.B., Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev., 11 (1986) 157-198.
16. [16] Sattin, A. and Rall, T.W., The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′,5′-phosphate content of guinea pig cerebral cortex slices, Mol. Pharmacol., 6 (1970) 13-23.
17. [17] Schiffmann, S.N. and Vanderhaeghen, J.-J., Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons, J. Neurosci., 13 (1993) 1080-1087.
18. [18] Self, D.W., Terwilliger, R.Z., Nestler, E.J. and Stein, L., Inactivation of Gi and Go proteins in nucleus accumbens reduces both cocaine and heroin reinforcement, J. Neurosci., 14 (1994) 6239-6247.
19. [19] Self, D.W. and Nestler, E.J., Molecular mechanisms of drug reinforcement and addiction, Annu. Rev. Neurosci., 18 (1995) 463-495.
20. [20] Snyder, S.H., Katims, J.J., Annau, Z., Bruns, R.F. and Daly, J.W., Adenosine receptors and behavioral actions of methylxanthines, Proc. Natl. Acad. Sci. USA, 78 (1981) 3260-3264.
21. [21] Thithapandha, A., Maling, H.M. and Gillete, J.R., Effects of caffeine and theophylline on activity of rats in relation to brain xanthine concentrations, Proc. Soc. Exp. Biol. Med., 139 (1972) 582-586.
22. [22] Wolf, M.E., White, F.J., Nassar, R., Brooderson, R.J. and Khansa, M.R., Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization, J. Pharmacol. Exp. Ther., 264 (1993) 249-255.
23. [23] Wolf, M.E., White, F.J. and Hu, X.-T., MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine, J. Neurosci., 14 (1994) 1735-1745.